Theralase Technologies (TTX) Financial Statements

1 Followers

Theralase Technologies Financial Overview

Theralase Technologies's market cap is currently €34.72M. The company's EPS TTM is €-0.0105; its P/E ratio is -12.94; Theralase Technologies is scheduled to report earnings on May 29, 2026, and the estimated EPS forecast is €>-0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Dec 24	Dec 23	Mar 23	Mar 22
Income Statement
Total Revenue	C$ 816.47K	C$ 1.03M	C$ 1.07M	C$ 1.14M	C$ 780.64K
Gross Profit	C$ 241.51K	C$ 554.03K	C$ 562.13K	C$ 628.17K	C$ 309.94K
Operating Income	C$ -4.18M	C$ -4.29M	C$ -4.59M	C$ -5.20M	C$ -4.52M
EBITDA	C$ -3.91M	C$ -3.96M	C$ -4.25M	C$ -4.90M	C$ -4.31M
Net Income	C$ -4.12M	C$ -4.26M	C$ -4.57M	C$ -5.25M	C$ -4.42M
Balance Sheet
Cash & Short-Term Investments	C$ 182.91K	C$ 268.76K	C$ 43.91K	C$ 1.51M	C$ 3.69M
Total Assets	C$ 3.49M	C$ 3.25M	C$ 3.28M	C$ 4.16M	C$ 5.94M
Total Debt	C$ 458.05K	C$ 293.87K	C$ 386.88K	C$ 473.62K	C$ 35.72K
Net Debt	C$ 275.14K	C$ 25.11K	C$ 342.97K	C$ -1.03M	C$ -3.66M
Total Liabilities	C$ 1.72M	C$ 1.18M	C$ 1.37M	C$ 1.07M	C$ 874.79K
Stockholders' Equity	C$ 1.78M	C$ 2.07M	C$ 1.91M	C$ 3.09M	C$ 5.07M
Cash Flow
Free Cash Flow	C$ -3.33M	C$ -3.35M	C$ -4.11M	C$ -5.20M	C$ -4.13M
Operating Cash Flow	C$ -3.29M	C$ -3.33M	C$ -4.07M	C$ -5.13M	C$ -4.03M
Investing Cash Flow	C$ -48.94K	C$ -19.97K	C$ -37.27K	C$ -70.41K	C$ -100.82K
Financing Cash Flow	C$ 3.25M	C$ 3.57M	C$ 2.65M	C$ 3.02M	C$ -57.37K

Currency in CAD

Theralase Technologies Earnings and Revenue History

Income Statement >

Theralase Technologies Debt to Assets

Balance Sheet >

Theralase Technologies Cash Flow

Cash Flow >

Theralase Technologies Forecast EPS vs Actual EPS

Earnings >